A cross-sectional study on demoralization in prostate cancer patients: the role of masculine self-esteem, depression, and resilience

Abstract

Purpose The current cross-sectional study had three objectives: (1) to assess the prevalence of depression and demoralization in a sample of prostate cancer (PCa) patients; (2) to examine whether masculine self-esteem and depression were associated with demoralization; and (3) to evaluate the role of resilience as a factor buffering the effects of masculine self-esteem and depression on demoralization. Methods 197 PCa patients aged 48 to 79 years (M = 67.19; SD = 6.83) answered questions about masculine self-esteem, depression, resilience, and demoralization. An ANOVA was conducted to examine whether the association between demoralization and depressive symptoms was linear. A chi-square test was calculated to determine differences between depression and demoralization. Finally, a hierarchical multiple linear regression analysis with interaction terms was conducted to examine the associations between masculine self-esteem, depression, resilience, and demoralization. Results Depression scores increased linearly with demoralization severity, but demoralization scores were higher than depression scores (21.3% vs. 15.2%). Lower scores on masculine self-esteem and higher scores on depressive symptoms were associated with greater demoralization. Resilience significantly moderated the association between masculine self-esteem and demoralization, but not between depression and demoralization. Conclusion Assessment of depression, masculine self-esteem, resilience, and demoralization in the clinical setting is critical for improving the mental health status of PCa patients.

Machine Learning and Clinical-Radiological Characteristics for the Classification of Prostate Cancer in PI-RADS 3 Lesions

“…Prostate cancer (PCa) is the most frequent male malignancy and the third cause of cancer death in European men [ 1 , 2 , 3 , 4 , 5 ]. Clinical suspicion of PCa is based on an elevated serum prostate-specific antigen (PSA) level and an abnormal digital rectal examination in biopsy-naïve men.…”

Immunotherapy for Urological Tumors on YouTubeTM: An Information-Quality Analysis

“…Specifically, despite the scientific interest in PCa treatment options, only 20 YouTube™ videos concerning IMT for PCa were recorded in the current analysis. The role of IMT in PCa is not deeply studied yet and not attractive for SoMe platforms with respect to surgical, radiotherapy, or medical approaches and their consequences [ 27 , 28 ].…”

“…The spread of high-quality information on IMT through social media might represent a potential instrument for education by physicians and by general users who are interested into the topic. Specifically, for patients affected by IMT-eligible diseases, access to more information could increase their awareness in order to make the diagnostic–therapeutic steps more manageable [ 25 , 26 , 27 , 28 , 29 ].…”

Could YouTubeTM encourage men on prostate checks? A contemporary analysis

“…diagnosis: The 5-year survival rate is 100% in patients diagnosed with the earliest stage disease and less than 33% if diagnosed at the latest stage (4)(5)(6)(7). Screening is the best way for PCa early diagnosis and it is recommended to all men with no risk factors over 50 years (8,9).…”